The 1998 Raun characterisation paper documented Ipamorelin's selectivity profile GH release without prolactin, ACTH, cortisol, or aldosterone elevations characteristic of earlier GHRPs (PMID 9849822)
It might help control hunger and balance blood sugar alongside other weight-loss treatments
The stated rationale was safety concerns, though many clinicians and compounding pharmacy groups argued the agency overstepped, noting that no specific safety signal justified the restriction for most of the affected peptides
Product focus: We noted whether a supplier is a single-vial vendor or a GMP peptide manufacturer that runs solid-phase synthesis under contract
It is also widely discussed online for hair growth and injectable peptide therapy, but those claims vary substantially in evidence strength
Why I Stepped Into Policy As a physician, I used to think advocacy wasnt my lane